|
|
General Thoracic-Lung
|
|
|
Green glow locates tumors during surgery
NATIONAL HARBOR, MD. - Seeing is believing, especially when enhanced visualization of tumors during surgery helps improve chances for complete resection, investigators said at the annual Society of Surgical Oncology Cancer Symposium. With near-infrared (NIR) fluorescence imaging and a portable... »
Crizotinib changes practice for ALK-positive NSCLC
VIENNA – Long-awaited data from the phase III PROFILE 1007 confirm that crizotinib provides superior progression-free survival and responses, compared with second-line chemo-therapy in advanced anaplastic lymphoma kinase–positive non–small cell lung cancer.
Median progression-free survival more... » BOSTON – Delivering stereotactic body radiation for early-stage, inoperable non–small cell lung cancer doubled overall survival rates achieved in historical series with conventional radiation, investigators reported at the annual meeting of the American Society for Radiation Oncology.
The 3-year... » The prevalence of chronic obstructive pulmonary disease is 6% nationwide, but varies from less than 4% in Washington and Minnesota to more than 9% in Alabama and Kentucky, according to data from the Centers for Disease Control and Prevention. The findings were published in the CDC’s Morbidity and... » CHICAGO – Limiting CT follow-up of incidental pulmonary nodules to a small area around the suspicious nodule may help resolve a common clinical dilemma and an Achilles heel of lung cancer screening, researchers suggest.
It could also reduce the radiation dose by more than 80%.
"Why should we... »
Stereotactic body radiation boosts NSCLC survival
COPD varies by state, peaks above 9%
Targeted CT follow-up for incidental lung nodules?
FT. LAUDERDALE, FLA. – Pretreatment staging of presumed N0 non–small cell lung cancer (NSCLC) misses unsuspected lymph node metastases that are subsequently discovered during surgical specimen evaluation in 10%-25% of cases.... »
More NSCLC Upstaging Seen With Thoracotomy
FT. LAUDERDALE, FLA. – Pretreatment staging of presumed N0 non–small cell lung cancer (NSCLC) misses unsuspected lymph node metastases that are subsequently discovered during surgical specimen evaluation in 10%-25% of cases.... »
Resection Works Well for High-Risk NSCLC Patients
COLORADO SPRINGS – Patients with stage 1a non–small cell lung cancer deemed medically inoperable or high risk can undergo surgical resection safely and with excellent results, judging by results of a single-center... »
| Jun 26 - 29 Coeur d'Alene, ID | Western Thoracic Surgical Association (WTSA): Annual Meeting |
| Jun 27 - 29 Frankfurt, | Congenital and Structural Interventions (CSI 2013) |
| Oct 31 - Nov 2 Chicago, IL | American Society for Radiation Oncology (ASTRO): Chicago Multidisciplinary Symposium in Thoracic Oncology |